NCT04055649: ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 62 planned
- Started
- 21 Jan 2020
- Primary completion
- 28 May 2027
- Arms
- Treatment - ONC201 & Paclitaxel
- Results
- None posted
- 14 Aug 2019: Trial registered
- 21 Jan 2020: Trial started